These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37429260)

  • 1. Ceramide Analog 5cc Overcomes TRAIL Resistance by Enhancing JNK Activation and Repressing XIAP Expression in Metastatic Colon Cancer Cells.
    Huang Q; Liu F
    Chemotherapy; 2023; 68(4):210-218. PubMed ID: 37429260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceramide targets xIAP and cIAP1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression.
    Paschall AV; Zimmerman MA; Torres CM; Yang D; Chen MR; Li X; Bieberich E; Bai A; Bielawski J; Bielawska A; Liu K
    BMC Cancer; 2014 Jan; 14():24. PubMed ID: 24422988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sea Cucumber (
    Kim JL; Park SH; Jeong S; Kim BR; Na YJ; Jo MJ; Jeong YA; Yun HK; Kim DY; Kim BG; You S; Oh SC; Lee DH
    Nutrients; 2019 May; 11(5):. PubMed ID: 31083595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein.
    Voelkel-Johnson C; Hannun YA; El-Zawahry A
    Mol Cancer Ther; 2005 Sep; 4(9):1320-7. PubMed ID: 16170023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
    Dai Y; Liu M; Tang W; Li Y; Lian J; Lawrence TS; Xu L
    BMC Cancer; 2009 Nov; 9():392. PubMed ID: 19895686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma.
    Ndozangue-Touriguine O; Sebbagh M; Mérino D; Micheau O; Bertoglio J; Bréard J
    Oncogene; 2008 Oct; 27(46):6012-22. PubMed ID: 18560353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
    Kauntz H; Bousserouel S; Gossé F; Raul F
    Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode.
    Gillissen B; Richter A; Richter A; Overkamp T; Essmann F; Hemmati PG; Preissner R; Belka C; Daniel PT
    Cell Death Dis; 2013 May; 4(5):e643. PubMed ID: 23703388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models.
    Mahalingam D; Carew JS; Espitia CM; Cool RH; Giles FJ; de Jong S; Nawrocki ST
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31248045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells.
    Vogler M; Dürr K; Jovanovic M; Debatin KM; Fulda S
    Oncogene; 2007 Jan; 26(2):248-57. PubMed ID: 16832350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells.
    Sinicrope FA; Penington RC; Tang XM
    Clin Cancer Res; 2004 Dec; 10(24):8284-92. PubMed ID: 15623604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific down-regulation of XIAP with RNA interference enhances the sensitivity of canine tumor cell-lines to TRAIL and doxorubicin.
    Spee B; Jonkers MD; Arends B; Rutteman GR; Rothuizen J; Penning LC
    Mol Cancer; 2006 Sep; 5():34. PubMed ID: 16953886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP; Zisman A; Bonavida B
    Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
    Shi RX; Ong CN; Shen HM
    Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
    Yano K; Horinaka M; Yoshida T; Yasuda T; Taniguchi H; Goda AE; Wakada M; Yoshikawa S; Nakamura T; Kawauchi A; Miki T; Sakai T
    Int J Oncol; 2011 Feb; 38(2):365-74. PubMed ID: 21165560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHA-mediated enhancement of TRAIL-induced apoptosis in colon cancer cells is associated with engagement of mitochondria and specific alterations in sphingolipid metabolism.
    Skender B; Hofmanová J; Slavík J; Jelínková I; Machala M; Moyer MP; Kozubík A; Hyršlová Vaculová A
    Biochim Biophys Acta; 2014 Sep; 1841(9):1308-17. PubMed ID: 24953781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.
    Nakshatri H; Rice SE; Bhat-Nakshatri P
    Oncogene; 2004 Sep; 23(44):7330-44. PubMed ID: 15286701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
    Tu SP; Sun YW; Cui JT; Zou B; Lin MC; Gu Q; Jiang SH; Kung HF; Korneluk RG; Wong BC
    Cancer; 2010 Mar; 116(5):1252-63. PubMed ID: 20082449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.
    Büneker CK; Yu R; Deedigan L; Mohr A; Zwacka RM
    Cancer Lett; 2012 Mar; 316(2):168-77. PubMed ID: 22104728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis.
    Liu F; Hu X; Zimmerman M; Waller JL; Wu P; Hayes-Jordan A; Lev D; Liu K
    PLoS One; 2011 Jan; 6(1):e16241. PubMed ID: 21264227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.